Martingale Asset Management L P Krystal Biotech, Inc. Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 5,135 shares of KRYS stock, worth $910,897. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,135

Previous 5,135 -0.0%

Holding current value

$910,897

Previous $942,000 0.96%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$153.12 - $183.64 $107,030 - $128,364	-699 Reduced 11.98%	5,135 $942,000
Q1 2024 May 14, 2024	SELL	$108.01 - $179.35 $632,182 - $1.05 Million	-5,853 Reduced 50.08%	5,834 $1.04 Million
Q4 2023 Feb 12, 2024	SELL	$96.0 - $128.29 $7,680 - $10,263	-80 Reduced 0.68%	11,687 $1.45 Million
Q3 2023 Nov 14, 2023	SELL	$108.51 - $130.22 $32,661 - $39,196	-301 Reduced 2.49%	11,767 $1.36 Million
Q2 2023 Aug 11, 2023	SELL	$78.48 - $130.32 $120,859 - $200,692	-1,540 Reduced 11.32%	12,068 $1.42 Million
Q4 2022 Feb 13, 2023	BUY	$63.14 - $79.9 $568,575 - $719,499	9,005 Added 195.63%	13,608 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $298,504 - $379,287	4,603 New	4,603 $321,000
Q4 2021 Feb 11, 2022	SELL	$39.81 - $88.24 $533,692 - $1.18 Million	-13,406 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$52.01 - $71.77 $358,869 - $495,213	6,900 Added 106.06%	13,406 $699,000
Q2 2021 Aug 13, 2021	SELL	$62.14 - $81.82 $6,214 - $8,181	-100 Reduced 1.51%	6,506 $442,000
Q1 2021 May 13, 2021	SELL	$59.42 - $85.46 $5,942 - $8,546	-100 Reduced 1.49%	6,606 $508,000
Q4 2020 Feb 10, 2021	SELL	$40.64 - $61.38 $1.13 Million - $1.7 Million	-27,700 Reduced 80.51%	6,706 $402,000
Q3 2020 Nov 12, 2020	SELL	$37.76 - $48.49 $868,442 - $1.12 Million	-22,999 Reduced 40.06%	34,406 $1.48 Million
Q2 2020 Aug 10, 2020	BUY	$37.03 - $60.0 $1.21 Million - $1.96 Million	32,605 Added 131.47%	57,405 $2.38 Million
Q1 2020 May 11, 2020	BUY	$35.02 - $65.64 $868,496 - $1.63 Million	24,800 New	24,800 $1.07 Million

Others Institutions Holding KRYS

# of Institutions

308

Shares Held

24.5M

Call Options Held

484K

Put Options Held

309K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.55B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Krystal Biotech, Inc. Transaction History